Cargando…

Safety and effectiveness of propranolol in severely burned patients: systematic review and meta-analysis

BACKGROUND: The objective of this systematic review was to determine the effectiveness and safety of propranolol compared to placebo or usual care for improving clinical relevant outcomes in severely burned patients (TBSA >20%). METHODS: Relevant articles from randomized controlled trials were id...

Descripción completa

Detalles Bibliográficos
Autores principales: Manzano-Nunez, Ramiro, García-Perdomo, Herney Andrés, Ferrada, Paula, Ordoñez Delgado, Carlos Alberto, Gomez, Diego Andrés, Foianini, Jorge Esteban
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5335497/
https://www.ncbi.nlm.nih.gov/pubmed/28265298
http://dx.doi.org/10.1186/s13017-017-0124-7
_version_ 1782512057584713728
author Manzano-Nunez, Ramiro
García-Perdomo, Herney Andrés
Ferrada, Paula
Ordoñez Delgado, Carlos Alberto
Gomez, Diego Andrés
Foianini, Jorge Esteban
author_facet Manzano-Nunez, Ramiro
García-Perdomo, Herney Andrés
Ferrada, Paula
Ordoñez Delgado, Carlos Alberto
Gomez, Diego Andrés
Foianini, Jorge Esteban
author_sort Manzano-Nunez, Ramiro
collection PubMed
description BACKGROUND: The objective of this systematic review was to determine the effectiveness and safety of propranolol compared to placebo or usual care for improving clinical relevant outcomes in severely burned patients (TBSA >20%). METHODS: Relevant articles from randomized controlled trials were identified by a literature search in MEDLINE, EMBASE, and CENTRAL. We included trials involving patients with a severe burn (>20% of total body surface area affected). Trials were eligible if they evaluated propranolol and compared to usual care or placebo. Two investigators independently assessed articles for inclusion and exclusion criteria and selected studies for the final analysis. We conducted a meta-analysis using a random-effects model. RESULTS: We included ten studies in our systematic review. These studies randomized a total of 1236 participants. There were no significant differences between propranolol and placebo with respect to mortality (RD −0.02 [95% CI −0.06 to 0.02]), sepsis (RD −0.03 [95% CI −0.09 to 0.04]), and the overall hospital stay (MD −0.37 [−4.52 to 3.78]). Propranolol-treated adults had a decrease in requirements of blood transfusions (MD −185.64 [95% CI −331.06 to −40.43]) and a decreased heart rate (MD −26.85 [95% CI −39.95 to −13.75]). CONCLUSIONS: Our analysis indicates that there were no differences in mortality or sepsis in severely burned patients treated with propranolol compared with those who had usual care or placebo. However, the use of propranolol in these patients resulted in lower requirements of blood transfusion and lower values of heart rate. The evidence synthesized in this systematic review is limited to conclude that propranolol reduces the length of hospital stay among severely burned patients. Future trials should assess the impact of propranolol on clinically relevant outcomes such as mortality and adverse events. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13017-017-0124-7) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5335497
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-53354972017-03-06 Safety and effectiveness of propranolol in severely burned patients: systematic review and meta-analysis Manzano-Nunez, Ramiro García-Perdomo, Herney Andrés Ferrada, Paula Ordoñez Delgado, Carlos Alberto Gomez, Diego Andrés Foianini, Jorge Esteban World J Emerg Surg Review BACKGROUND: The objective of this systematic review was to determine the effectiveness and safety of propranolol compared to placebo or usual care for improving clinical relevant outcomes in severely burned patients (TBSA >20%). METHODS: Relevant articles from randomized controlled trials were identified by a literature search in MEDLINE, EMBASE, and CENTRAL. We included trials involving patients with a severe burn (>20% of total body surface area affected). Trials were eligible if they evaluated propranolol and compared to usual care or placebo. Two investigators independently assessed articles for inclusion and exclusion criteria and selected studies for the final analysis. We conducted a meta-analysis using a random-effects model. RESULTS: We included ten studies in our systematic review. These studies randomized a total of 1236 participants. There were no significant differences between propranolol and placebo with respect to mortality (RD −0.02 [95% CI −0.06 to 0.02]), sepsis (RD −0.03 [95% CI −0.09 to 0.04]), and the overall hospital stay (MD −0.37 [−4.52 to 3.78]). Propranolol-treated adults had a decrease in requirements of blood transfusions (MD −185.64 [95% CI −331.06 to −40.43]) and a decreased heart rate (MD −26.85 [95% CI −39.95 to −13.75]). CONCLUSIONS: Our analysis indicates that there were no differences in mortality or sepsis in severely burned patients treated with propranolol compared with those who had usual care or placebo. However, the use of propranolol in these patients resulted in lower requirements of blood transfusion and lower values of heart rate. The evidence synthesized in this systematic review is limited to conclude that propranolol reduces the length of hospital stay among severely burned patients. Future trials should assess the impact of propranolol on clinically relevant outcomes such as mortality and adverse events. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13017-017-0124-7) contains supplementary material, which is available to authorized users. BioMed Central 2017-03-02 /pmc/articles/PMC5335497/ /pubmed/28265298 http://dx.doi.org/10.1186/s13017-017-0124-7 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Review
Manzano-Nunez, Ramiro
García-Perdomo, Herney Andrés
Ferrada, Paula
Ordoñez Delgado, Carlos Alberto
Gomez, Diego Andrés
Foianini, Jorge Esteban
Safety and effectiveness of propranolol in severely burned patients: systematic review and meta-analysis
title Safety and effectiveness of propranolol in severely burned patients: systematic review and meta-analysis
title_full Safety and effectiveness of propranolol in severely burned patients: systematic review and meta-analysis
title_fullStr Safety and effectiveness of propranolol in severely burned patients: systematic review and meta-analysis
title_full_unstemmed Safety and effectiveness of propranolol in severely burned patients: systematic review and meta-analysis
title_short Safety and effectiveness of propranolol in severely burned patients: systematic review and meta-analysis
title_sort safety and effectiveness of propranolol in severely burned patients: systematic review and meta-analysis
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5335497/
https://www.ncbi.nlm.nih.gov/pubmed/28265298
http://dx.doi.org/10.1186/s13017-017-0124-7
work_keys_str_mv AT manzanonunezramiro safetyandeffectivenessofpropranololinseverelyburnedpatientssystematicreviewandmetaanalysis
AT garciaperdomoherneyandres safetyandeffectivenessofpropranololinseverelyburnedpatientssystematicreviewandmetaanalysis
AT ferradapaula safetyandeffectivenessofpropranololinseverelyburnedpatientssystematicreviewandmetaanalysis
AT ordonezdelgadocarlosalberto safetyandeffectivenessofpropranololinseverelyburnedpatientssystematicreviewandmetaanalysis
AT gomezdiegoandres safetyandeffectivenessofpropranololinseverelyburnedpatientssystematicreviewandmetaanalysis
AT foianinijorgeesteban safetyandeffectivenessofpropranololinseverelyburnedpatientssystematicreviewandmetaanalysis